Insmed Incorporated

Healthcare

NASDAQ:INSM · NASDAQ Global Select

Market Cap $21.34B Beta 0.77 P/E (TTM) -17.4

$95.80 -2.77%

-$2.73 today

52W Low $90.39High $212.75

Vol 16.08M · Avg 3.31M

EPS (TTM) -$5.49Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-9.13%

Period High

$211.41

Period Low

$91.88

Latest

$95.80

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Cardinal Health, Inc.

NYSE:CAH

$52.00B

Takeda Pharmaceutical Company Limited

NYSE:TAK

$49.39B

Humana Inc.

NYSE:HUM

$43.33B

Haleon plc

NYSE:HLN

$39.60B

Agilent Technologies, Inc.

NYSE:A

$35.95B

Alcon Inc.

NYSE:ALC

$31.56B

BeOne Medicines Ltd.

NASDAQ:ONC

$28.91B

GE HealthCare Technologies Inc.

NASDAQ:GEHC

$28.07B

IQVIA Holdings Inc.

NYSE:IQV

$28.02B

ResMed Inc.

NYSE:RMD

$27.35B

What is the latest INSM filing?

The latest filing shown is 4 dated Jun 10, 2026.

How many recent filings does INSM have?

Intrinsic Alpha currently shows 20 recent filings for INSM.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.